Access cutting-edge diabetic macular edema treatment through this clinical trial at a research site in Mesa. Study-provided care at no cost to qualified participants.
Access diabetic macular edema specialists in Mesa at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic macular edema treatment provided free
This study will evaluate the efficacy, safety, and Pharmacokinetics (PK) of the PDS with ranibizumab in participants with DME when treated every 24 weeks (Q24W) compared with intravitreal (IVT) ranibizumab 0.5 milligrams (mg) every 4 weeks (Q4W). The substudy will evaluate safety of re-implanting the updated PDS with ranibizumab and the refill-exchange procedures following re-implantation in participants with DME who were previously enrolled in the main study, GR40550. Up to 100 participants fr
Sponsor: Hoffmann-La Roche
Check if you qualify for this diabetic macular edema clinical trial in Mesa, AZ
If you're searching for diabetic macular edema treatment options in Mesa, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mesa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic macular edema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.